EXPRESSION AND SEXUAL DIMORPHISM OF GALANIN MESSENGER-RIBONUCLEIC-ACID IN GROWTH HORMONE-RELEASING HORMONE NEURONS OF THE RAT DURING DEVELOPMENT

被引:31
|
作者
DELEMARREVANDEWAAL, HA
BURTON, KA
KABIGTING, EB
STEINER, RA
CLIFTON, DK
机构
[1] UNIV WASHINGTON, DEPT OBSTET & GYNECOL, SEATTLE, WA 98195 USA
[2] UNIV WASHINGTON, DEPT PHYSIOL & BIOPHYS, SEATTLE, WA 98195 USA
[3] UNIV WASHINGTON, POPULAT CTR RES REPROD, SEATTLE, WA 98195 USA
[4] FREE UNIV AMSTERDAM HOSP, DEPT PEDIAT, 1081 HV AMSTERDAM, NETHERLANDS
关键词
D O I
10.1210/en.134.2.665
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In the rat, the secretion of GH is episodic and sexually dimorphic. The development and regulation of this patterning of GH secretion are governed by the reciprocal influence of the hypothalamic peptide somatostatin and GH-releasing hormone (GHRH). Galanin is a neuropeptide that is colocalized with GHRH in hypothalamic neurons and is thought to be involved in generating the episodic pattern of GH secretion. We hypothesized that galanin mRNA expression in GHRH neurons increases over development in both sexes, and that in the adults, galanin expression in GHRH neurons is greater in males than in females. To test these hypotheses, we used a double label in situ hybridization procedure to detect and measure galanin mRNA expression in GHRH neurons in the rat brain. GHRH mRNA-positive cells were visualized by an alkaline phosphatase color reaction, and galanin mRNA levels were measured by counting autoradiographic grains over individual GHRH mRNA-positive cells. Galanin mRNA coexpression was found in GHRH mRNA-containing cells of the arcuate nucleus, periarcuate area, and ventromedial hypothalamus. In both males and females there was a significant increase in galanin mRNA in GHRH neurons over development. Galanin mRNA levels in GHRH neurons of 10- and 25-day-old rats were higher in females than in males [10-day-old: females, 12 +/- 2; males, 6 +/- 1 grains/cell (P < 0.05); 25-day-old:females, 28 +/- 4; males, 15 +/- 3 grains/cell (P < 0.02)]. In adults (70 days), galanin mRNA levels in GHRH neurons were significantly higher in males than in females (males, 54 +/- 4; females, 32 +/- 3 grains/ cell; P < 0.005). In the adult rat, galanin mRNA levels in the individual hypothalamic areas exhibited a significant sexual dimorphism in the arcuate nucleus and periarcuate area, with higher levels in the male, whereas no sexual dimorphism was observed in the ventromedial hypothalamus. To determine whether galanin gene expression is influenced by circulating levels of testosterone, we measured galanin mRNA levels in castrated male rats with and without testosterone replacement. Castration reduced galanin message levels in GHRH neurons (intact, 73 +/- 6; castrate, 57 +/- 4 grains/cell), and although this reduction was not statistically significant (P = similar to 0.07), testosterone replacement significantly increased galanin message content (castrate/sham, 58 +/- 4 grains/cell; castrate plus testosterone replacement, 77 +/- 5 grains/ cell; P < 0.02) to intact levels (intact, 73 +/- 6 grains/cell). In summary, galanin message expression in GHRH neurons of both male and female rats increases over development. In adults, male GHRH neurons contain higher levels of galanin mRNA than those of females, and this difference is probably due at least in part to differences in circulating testosterone levels. These observations support the hypothesis that sexual dimorphism in the GH secretory system is related to sex-dependent differences in galanin gene expression of GHRH neurons.
引用
收藏
页码:665 / 671
页数:7
相关论文
共 50 条
  • [1] GROWTH HORMONE-RELEASING HORMONE MESSENGER-RIBONUCLEIC-ACID IN THE HYPOTHALAMUS OF THE ADULT MALE-RAT IS INCREASED BY TESTOSTERONE
    ZEITLER, P
    ARGENTE, J
    CHOWENBREED, JA
    CLIFTON, DK
    STEINER, RA
    ENDOCRINOLOGY, 1990, 127 (03) : 1362 - 1368
  • [2] SEXUAL DIMORPHISM OF GROWTH HORMONE-RELEASING HORMONE AND SOMATOSTATIN GENE-EXPRESSION IN THE HYPOTHALAMUS OF THE RAT DURING DEVELOPMENT
    ARGENTE, J
    CHOWEN, JA
    ZEITLER, P
    CLIFTON, DK
    STEINER, RA
    ENDOCRINOLOGY, 1991, 128 (05) : 2369 - 2375
  • [3] Expression of functional estrogen receptors and galanin messenger ribonucleic acid in immortalized luteinizing hormone-releasing hormone neurons:: Estrogenic control of galanin gene expression
    Shen, ES
    Meade, EH
    Pérez, MC
    Deecher, DC
    Negro-Vilar, A
    López, FJ
    ENDOCRINOLOGY, 1998, 139 (03) : 939 - 948
  • [4] EXPRESSION AND LOCALIZATION OF GROWTH HORMONE-RELEASING HORMONE MESSENGER-RIBONUCLEIC-ACID IN RAT PLACENTA - INVITRO SECRETION AND REGULATION OF ITS PEPTIDE PRODUCT
    MARGIORIS, AN
    BROCKMANN, G
    BOHLER, HCL
    GRINO, M
    VAMVAKOPOULOS, N
    CHROUSOS, GP
    ENDOCRINOLOGY, 1990, 126 (01) : 151 - 158
  • [5] ONTOGENY AND PITUITARY REGULATION OF TESTICULAR GROWTH HORMONE-RELEASING HORMONE-LIKE MESSENGER-RIBONUCLEIC-ACID
    BERRY, SA
    PESCOVITZ, OH
    ENDOCRINOLOGY, 1990, 127 (03) : 1404 - 1411
  • [6] ONTOGENY AND SEXUAL DIMORPHISM OF RAT GROWTH-HORMONE MESSENGER-RIBONUCLEIC-ACID AS STUDIED BY INSITU HYBRIDIZATION
    MARTINOLI, MG
    PELLETIER, G
    JOURNAL OF NEUROENDOCRINOLOGY, 1990, 2 (05) : 613 - 619
  • [7] EFFECT OF HYPOPHYSECTOMY AND GROWTH-HORMONE REPLACEMENT ON HYPOTHALAMIC GROWTH HORMONE-RELEASING FACTOR MESSENGER-RIBONUCLEIC-ACID LEVELS
    ECCLESTON, LM
    POWELL, JF
    CLAYTON, RN
    JOURNAL OF NEUROENDOCRINOLOGY, 1991, 3 (06) : 661 - 668
  • [8] Glucocorticoids regulate pituitary growth hormone-releasing hormone receptor messenger ribonucleic acid expression
    Miller, TL
    Mayo, KE
    ENDOCRINOLOGY, 1997, 138 (06) : 2458 - 2465
  • [9] GONADOTROPIN-RELEASING-HORMONE RECEPTOR MESSENGER-RIBONUCLEIC-ACID EXPRESSION IN RAT OVARY
    WHITELAW, PF
    EIDNE, KA
    SELLAR, R
    SMYTH, CD
    HILLIER, SG
    ENDOCRINOLOGY, 1995, 136 (01) : 172 - 179
  • [10] GROWTH HORMONE-RELEASING HORMONE-LIKE MESSENGER-RIBONUCLEIC-ACID AND IMMUNOREACTIVE PEPTIDE ARE PRESENT IN HUMAN TESTIS AND PLACENTA
    BERRY, SA
    SRIVASTAVA, CH
    RUBIN, LR
    PHIPPS, WR
    PESCOVITZ, OH
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 75 (01): : 281 - 284